• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL0601180 萘二磺酸乙乳胆铵 aclatonium napadisilate Active ingredient Chemical Drugs(3.1) New Drug Application 2007-01-17 安徽省新星药物开发有限责任公司 Anhui New Star Pharmaceutical Development Co Ltd Certificate Issued 2010-10-28 view
CXHL0601181 萘二磺酸乙乳胆铵胶囊 aclatonium napadisilate Capsule Chemical Drugs(3.1) New Drug Application 2007-01-17 安徽省新星药物开发有限责任公司 Anhui New Star Pharmaceutical Development Co Ltd Certificate Issued 2010-11-02 view
CXHL0700564 萘二磺乙乳胆铵 aclatonium napadisilate Active ingredient Chemical Drugs(3.1) New Drug Application 2008-02-25 扬子江药业集团江苏海慈生物药业有限公司 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co Ltd Certificate Issued 2009-04-21 view
CXHL0700565 萘二磺乙乳胆铵胶囊 aclatonium napadisilate Capsule Chemical Drugs(3.1) New Drug Application 2008-02-25 扬子江药业集团有限公司 Yangtze River Pharmaceutical (Group) Co Ltd Certificate Issued 2009-04-21 view
CXHL0900347 萘二磺乙乳胆铵 aclatonium napadisilate Active ingredient Chemical Drugs(3.1) New Drug Application 2009-10-26 扬子江药业集团江苏海慈生物药业有限公司 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co Ltd Certificate Issued 2014-07-02 view
CXHL0900348 萘二磺乙乳胆铵胶囊 aclatonium napadisilate Capsule Chemical Drugs(3.1) New Drug Application 2009-10-26 扬子江药业集团有限公司 Yangtze River Pharmaceutical (Group) Co Ltd Certificate Issued 2014-07-02 view